NYSE · Healthcare · Drug Manufacturers - General
Organon & Co.
OGN
Organon & Co. CEO Joseph T. Morrissey Jr. · Market cap $3.5B.
$13.32
+0.01 · +0.11%
52w hi $13.4452w lo $5.69
Off 52w high 0.9%
59
ROUTINE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Sell
Avg PT $11.33
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 06 | Lynette Holzbaur | SVP and Corporate Controller | Buy | 26,448 | $13.35 | +$353K | 59 |
| Nov 12 | COX CARRIE SMITH | Executive Chair | Buy | 65,400 | $7.67 | +$502K | 58 |
| May 14 | COX CARRIE SMITH | Buy | 12,469 | $8.07 | +$101K | 63 | |
| May 07 | Aaron Falcione | Chief Human Resources Officer | Buy | 5,500 | $8.77 | +$48K | 65 |
| May 06 | Kirke Weaver | Gen. Counsel & Corp. Secy. | Buy | 8,045 | $9.21 | +$74K | 70 |
| May 06 | Daniel Karp | Executive VP, Corp. Dev. | Buy | 3,500 | $8.24 | +$29K | 65 |
| May 05 | Kevin Ali | Chief Executive Officer | Buy | 34,000 | $8.80 | +$299K | 75 |
| May 05 | Matthew M Walsh | Chief Financial Officer | Buy | 11,400 | $8.82 | +$101K | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay